Plasmodium yoelii: Influence of antimalarial treatment on acquisition of immunity in BALB/c and DBA/2 mice

Experimental Parasitology

Volumn 116, Issue 3, 2007, Pages 266-272

  Ma, Shi hong ^a   Zheng, Li ^a   Liu, Ying jie ^a   Guo, Sheng yu ^a   Feng, Hui ^a   Chen, Guang ^a   Li, Dong mei ^a   Wang, Ji chun ^a   Cao, Ya ming ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Acquired Immunity; Antimalarial treatment; AR; artesunate; chloroquine; CQ; ELISA; enzyme linked immunosorbent assay; FCS; fetal calf serum; IFN ; interferon gamma; lethal strain of Plasmodium yoelii 17X; PI; Plasmodium yoelii; post infection; Py17XL; Py17XNL, nonlethal strain of Plasmodium yoelii 17X; room temperature; rt; Un; untreated; WHO; World Health Organization

Indexed keywords

ARTESUNATE; CHLOROQUINE; GAMMA INTERFERON; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL INFECTION; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION PREVENTION; INTERFERON PRODUCTION; MALARIA; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM YOELII; PRIMARY INFECTION; PRIORITY JOURNAL; PROVOCATION TEST; REINFECTION; SPLEEN CELL;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; FEMALE; IMMUNOGLOBULIN G; INTERFERON TYPE II; MALARIA; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; PARASITEMIA; PLASMODIUM YOELII; RECURRENCE; SESQUITERPENES;

ARTESUNATE; MUS; PLASMODIUM YOELII; RODENTIA;

EID: 34248180574     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2007.01.007     Document Type: Article

References (23)

1. Bygbjerg I.C., and Flachs H. Effect of chloroquine on human lymphocyte proliferation. Transactions of the Royal Society of Tropical Medicine and Hygiene 2 (1986) 231-235
2. Cao Y.M., Tsuboi T., and Torii M. Nitric oxide inhibits the development of Plasmodium yoelii gametocytes into gametes. Parasitology International 47 (1998) 157-166
3. Chattopadhyay R., Sharma A., Srivastava V.K., Pati S.S., Sharma S.K., Das B.S., and Chitnis C.E. Plasmodium falciparum infection elicits both variant-specific and cross-reactive antibodies against parasite variant antigens. Infection and Immunity 71 (2003) 597-604
4. Elias R.M., Sardinha L.R., Bastos K.R., Zago C.A., da Silva A.P., Alvarez J.M., and Lima M.R. Role of CD28 in polyclonal and specific T and B cell responses required for protection against blood stage malaria. Journal of Immunology 174 (2005) 790-799
5. Favre N., Ryffel B., Bordmann G., and Rudinm W. The course of Plasmodium chabaudi chabaudi infections in interferon-gamma receptor deficient mice. Parasite Immunology 19 (1997) 375-383
6. Gatton M.L., and Cheng Q. Modeling the development of acquired clinical immunity to Plasmodium falciparum malaria. Infection and Immunity 72 (2004) 6538-6545
7. Hugosson E., Bjorkman A., and Troye-Blomberg M. Chloroquine enhances the number of IL-10 producing cells and the expression of B7-2 and ICAM-1 in in vitro-cultured PBMC. Scandinavian Journal of Immunology 55 (2002) 399-408
8. Hviid L. Naturally acquired immunity to Plasmodium falciparum malaria in Africa. Acta Tropica 95 (2005) 270-275
9. Legorreta-Herrera M., Ventura-Ayala M.L., Licona-Chavez R.N., Soto-Cruz I., and Hernandez-Clemente F.F. Early treatment during a primary malaria infection modifies the development of cross immunity. Parasite Immunology 26 (2004) 7-17
10. Lin P.Y., Feng Z.M., Pan J.Q., Zhang D., and Xiao L.Y. Effect of artesunate on immune function in mice. Acta Pharmacologica Sinica 5 (1995) 441-444
11. Long T.T., Nakazawa S., Huaman M.C., and Kanbara H. Influence of antimalarial treatment on acquisition of immunity in Plasmodium berghei NK65 malaria. Clinical Diagnostic Laboratory Immunology 9 (2002) 933-934
12. Luty A.J., Lell B., Schmidt-Ott R., Lehman L.G., Luckner D., Greve B., Matousek P., Herbich K., Schmid D., Migot-Nabias F., Deloron P., Nussenzweig R.S., and Kremsner P.G. Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. Journal of Infectious Diseases 179 (1999) 980-988
13. Malik E.M., Mohamed T.A., Elmardi K.A., Mowien R.M., Elhassan A.H., Elamin S.B., Mannan A.A., and Ahmed E.S. From chloroquine to artemisinin-based combination therapy: the Sudanese experience. Malarial Journal 5 (2006) 65-73
14. Murphy G.S., Basri H., Purnomo, Andersen E.M., Bangs M.J., Mount D.L., Gorden J., Lal A.A., Purwokusumo A.R., Harjosuwarno S., Sorensen K., and Hoffman S.L. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 341 (1993) 96-100
15. Picot S., Peyron F., Donadille A., Vuillez J.P., Barbe G., and Ambroise-Thomas P. Chloroquine-induced inhibition of the production of TNF, but not of IL-6, is affected by disruption of iron metabolism. Immunology 80 (1993) 127-133
16. Rosa R., Silveira H., Seixas E., Rolao N., Santos-Gomes G., and do Rosario V. The effect of chloroquine on the production of interferon-gamma, interleukin (IL)-4, IL-6, and IL-10 in Plasmodium chabaudi chabaudi in infected C57BL6 mice. Journal of Parasitology 85 (1999) 956-960
17. Salmeron G., and Lipsky P.E. Immunosuppressive potential of antimalarials. The American Journal of Medicine 1A (1983) 19-24
18. Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., and Hay S.I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434 (2005) 214-217
19. Stephens R., Albano F.R., Quin S., Pascal B.J., Harrison V., Stockinger B., Kioussis D., Weltzien H.U., and Langhorne J. Malaria-specific transgenic CD4(+) T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance. Blood 106 (2005) 1676-1684
20. Su Z., and Stevenson M.M. IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice. Journal of Immunology 168 (2002) 1348-1355
21. White N.J. Why is it that antimalarial drug treatments do not always work?. Annals of Tropical Medicine and Parasitology 92 (1998) 449-458
22. White N.J. Treatment of malaria. New England Journal of Medicine 335 (1996) 801-806
23. Zheng W., Liu J., Meng D.Y., Hu X.F., and Cao Y.M. Study of protective immunity against infection of Plasmodium yoelii 17XL in DBA/2 mice. Chinese Journal of Parasitology and Parasitic Diseases 24 (2006) 14-18